Skip to main navigation
Login · Contact

Akorn Pharmaceuticals

  • ABOUT US
    • Corporate Profile
    • Timeline
    • Operating Locations
    • Compliance
    • Code of Ethics
    • Quality Policy
  • OUR BUSINESSES
    • Generics
    • Brand Rx
    • Akorn Consumer Health
    • Akorn Animal Health
    • Akorn India
  • PRODUCTS
    • All Products
    • Download Catalogs
    • Return Goods Policy
  • BUSINESS DEVELOPMENT
    • Benefits of Partnering
  • INVESTOR RELATIONS
    • Stock Quote & Chart
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Annual Reports
    • Corporate Governance
    • Investor FAQs
    • IR Contacts
  • CAREERS
    • Who We Are
    • Why We Work Here
    • Career Opportunities
    • Benefits
Akorn Investor Relations

INVESTOR RELATIONS

Investor Relations Stock Quote & Chart Press Releases Events & Presentations SEC Filings Annual Reports Corporate Governance
Charters and Documents Management Board of Directors
Investor FAQs IR Contacts Contact Us

Tool Kit

E-mail Alerts Print Page RSS Feeds

Share Page

X
  • Share on:
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Reddit
  • Digg
  • Google
  • Delicious
  • StumbleUpon

  • Share this page through your favorite social channel or email this page to a colleague.

SEC Filing Details

Document Details

Form
4
Filing Date
09/07/18
Document Date
09/05/18
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Akorn, Inc.
Issuer
AKORN INC
Filer
BONACCORSI JOSEPH

Filing Formats

View HTML
Download PDF
Download DOC

Advancing The New Vision

  • Home
  • Contact Us
  • Legal & Privacy
  • Site Map

©Akorn, Incorporated | 1925 W. Field Court, Lake Forest, Illinois 60045 | 800.932.5676